BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12373673)

  • 21. Angelman syndrome: clinical findings and follow-up data of 14 patients.
    Kara B; Karaman B; Ozmen M; Rosti RO; Calişkan M; Kayserili H; Başaran S
    Turk J Pediatr; 2008; 50(2):137-42. PubMed ID: 18664077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spectrum of epilepsy and electroencephalogram patterns in Wolf-Hirschhorn syndrome: experience with 87 patients.
    Battaglia A; Filippi T; South ST; Carey JC
    Dev Med Child Neurol; 2009 May; 51(5):373-80. PubMed ID: 19379291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical and genetic diagnosis of Dravet syndrome: report of 20 cases].
    Siegler Z; Neuwirth M; Hegyi M; Paraicz E; Pálmafy B; Tegzes A; Barsi P; Karcagi V; Claes L; De Jonghe P; Herczegfalvi A; Fogarasi A
    Ideggyogy Sz; 2008 Nov; 61(11-12):402-8. PubMed ID: 19070316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cortical myoclonus in Angelman syndrome.
    Guerrini R; De Lorey TM; Bonanni P; Moncla A; Dravet C; Suisse G; Livet MO; Bureau M; Malzac P; Genton P; Thomas P; Sartucci F; Simi P; Serratosa JM
    Ann Neurol; 1996 Jul; 40(1):39-48. PubMed ID: 8687190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic counseling in Angelman syndrome: the challenges of multiple causes.
    Stalker HJ; Williams CA
    Am J Med Genet; 1998 Apr; 77(1):54-9. PubMed ID: 9557895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Smith-Magenis syndrome: a report of two new cases and an approximation to their characteristic behavioural phenotype].
    Blanco-Barca O; Gallego-Blanco M; Ruiz-Ponte C; Barros-Angueira F; Esquete-López C; Eirís-Puñal J; Castro-Gago M
    Rev Neurol; 2004 Jun 1-15; 38(11):1038-42. PubMed ID: 15202082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angelman syndrome: etiology, clinical features, diagnosis, and management of symptoms.
    Guerrini R; Carrozzo R; Rinaldi R; Bonanni P
    Paediatr Drugs; 2003; 5(10):647-61. PubMed ID: 14510623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angelman syndrome resulting from UBE3A mutations in 14 patients from eight families: clinical manifestations and genetic counselling.
    Moncla A; Malzac P; Livet MO; Voelckel MA; Mancini J; Delaroziere JC; Philip N; Mattei JF
    J Med Genet; 1999 Jul; 36(7):554-60. PubMed ID: 10424818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Phenotypic variability of deletion 22q11.2. An analysis of 16 observations with special emphasis on the neurological manifestations].
    Eirís-Puñal J; Iglesias-Meleiro JM; Blanco-Barca MO; Fuster-Siebert M; Barros-Angueira F; Ansede A; Castro-Gago M
    Rev Neurol; 2003 Oct 1-15; 37(7):601-7. PubMed ID: 14582013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The behavioural phenotype of Angelman syndrome.
    Horsler K; Oliver C
    J Intellect Disabil Res; 2006 Jan; 50(Pt 1):33-53. PubMed ID: 16316429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sleep polygraphy in Angelman syndrome.
    Miano S; Bruni O; Leuzzi V; Elia M; Verrillo E; Ferri R
    Clin Neurophysiol; 2004 Apr; 115(4):938-45. PubMed ID: 15003776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sleep in individuals with Angelman syndrome: parent perceptions of patterns and problems.
    Walz NC; Beebe D; Byars K
    Am J Ment Retard; 2005 Jul; 110(4):243-52. PubMed ID: 15941362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolution of seizures and electroencephalographical findings in 23 cases of deletion type Angelman syndrome.
    Uemura N; Matsumoto A; Nakamura M; Watanabe K; Negoro T; Kumagai T; Miura K; Ohki T; Mizuno S; Okumura A; Aso K; Hayakawa F; Kondo Y
    Brain Dev; 2005 Aug; 27(5):383-8. PubMed ID: 15963670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic imprinting and the expression of affect in Angelman syndrome: what's in the smile?
    Oliver C; Horsler K; Berg K; Bellamy G; Dick K; Griffiths E
    J Child Psychol Psychiatry; 2007 Jun; 48(6):571-9. PubMed ID: 17537073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angelman syndrome without detectable chromosome 15q11-13 anomaly: clinical study of familial and isolated cases.
    Laan LA; Halley DJ; den Boer AT; Hennekam RC; Renier WO; Brouwer OF
    Am J Med Genet; 1998 Mar; 76(3):262-8. PubMed ID: 9508247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angelman syndrome.
    Kyllerman M
    Handb Clin Neurol; 2013; 111():287-90. PubMed ID: 23622177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experimental functional analysis of aggression in children with Angelman syndrome.
    Strachan R; Shaw R; Burrow C; Horsler K; Allen D; Oliver C
    Res Dev Disabil; 2009; 30(5):1095-106. PubMed ID: 19361955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Progressive myoclonic epilepsy: clinical characteristics of 18 patients].
    Vistorte A; Sardiñas N; Esteban EM; Vargas-Díaz J; Novoa-López L; Rojas-Massippe E; Pestana EM
    Rev Neurol; 1999 Jul 16-31; 29(2):102-4. PubMed ID: 10528318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angelman syndrome due to a termination codon mutation of the UBE3A gene.
    Al-Maawali A; Machado J; Fang P; Dupuis L; Faghfoury H; Mendoza-Londono R
    J Child Neurol; 2013 Mar; 28(3):392-5. PubMed ID: 22566713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Prader-Willi syndrome and the Angelman syndrome.
    Vogels A; Fryns JP
    Genet Couns; 2002; 13(4):385-96. PubMed ID: 12558108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.